Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xseer Healthcare is an artificial intelligence-driven biotechnology company specializing in protein design and drug discovery. Based in China, the company leverages advanced deep learning algorithms and computational biology to accelerate the development of novel therapeutics for complex diseases. Their proprietary platform, X-Seed, integrates structural biology with high-performance computing to optimize target identification and lead generation. Xseer focuses on creating high-affinity binders and functional proteins, particularly within the fields of oncology and immunology. By combining dry-lab computation with wet-lab validation, the company aims to significantly improve the efficiency of the drug development lifecycle.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xseer Healthcare.